Covance, a global contract research organization, worked on all of the top 50 best-selling drugs available today through its full spectrum of nonclinical, clinical and commercialization services.
GSK and Covance Xcellerate® partner to leverage informatics technology in worldwide portfolio
Xcellerate® Informatics sets a new standard for monitoring of clinical trials. Read the blog.
Covance is dedicated to advancing healthcare and delivering Solutions Made Real®
With precision delivery of the largest volume of drug development data on the planet, we can help you identify new approaches and anticipate tomorrow’s challenges. Learn more about our history and services.
World Vaccine Congress Washington, April 2-5, Washington DC
Schedule a meeting with SME’s attending this event.
Save time and money by using a single BioA and central lab services provider.
Bundling these services can result in significant cost savings and faster turnaround times from study start through reports and data transfers. Learn more.
The Expanding Role of Single Site PMA in Companion Diagnostic Development
Join Covance Chief Scientific Officer Steven M. Anderson, PhD and Covance Vice President, Companion Diagnostics, Tom Turi, PhD on March 21 at 11 a.m. ET for a webinar on addressing the increasing demand for ssPMA models in the pursuit of CDx.
Introducing biosimilar CMC analytical master files
Innovative & invaluable solutions for biosimilar development. Pre-developed, risk-mitigated biosimilarity assessment, testing solutions, data evaluation and consultation.
Join Covance at our new state-of-the-art laboratory in a historic English locale
Covance York, UK BioCMC Lab Open House Date: 17 April 2018. Register now to attend half-day tour, scientific session and reception.
How do you ensure quality in global clinical trials?
Read our white paper for challenges and considerations in running a global trial.
Central Laboratory Services (ELMS)
Is your team more focused on managing referral labs than actual science?
As clinical trials become more complex, they require more specialty testing. There's a way to support this requirement without wasting valuable in-house resources on lab management.
Meet the CMA Team at Pharma Pricing and Market Access
20-21 March 2018, Business Design Center, London, Booth #19.
Find the right trial participants with a predictive biomarker strategy
Covance Chief Scientific Officer Steven M. Anderson, PhD and Covance Global Leader, Precision Medicine, Suso Platero, PhD discuss the importance of biomarkers in immuno-oncology development and effective patient recruitment.
Have you visited the NASH Education Center?
We’re pleased to announce the launch of the NASH Education Center. Access the latest thoughts from experts through webinars, case studies, blogs, info sheets and scientific articles.
Immuno-oncology education center
Learn about the latest advances in immuno-oncology. Download webinars, white papers, case studies and blogs.
Do you have the right precision medicine partner to optimize your program development?
The right partner can help you navigate the companion diagnostics journey from bench to bedside, starting with which pathway - IVD, LDT or both - is right for you.
Analytical methods for bioanalysis
Check out our recently updated nonproprietary assay list featuring more than 330 compounds.